Browse result page of CancerPDF Database
Please click on CancerPDF_ID for detailed information about peptide.
CancerPDF_ID | Peptide seq | Protein Name | Fluid | Mass/Z | Profiling Technique | Cancer Type | Expression Regulation | PUBMED ID |
---|---|---|---|---|---|---|---|---|
CancerPDF_ID3337 | NA | NA | Serum | 1546.43 | MALDI-TOF | Non-small cell lung cancer (NSCLC) | Downregulated in cancer vs normal | 22628229 |
CancerPDF_ID3338 | NA | NA | Serum | 7763.24 | MALDI-TOF | Non-small cell lung cancer (NSCLC) | Downregulated in cancer vs normal | 22628229 |
CancerPDF_ID3339 | NA | NA | Serum | 2883.76 | MALDI-TOF | Non-small cell lung cancer (NSCLC) | Upregulated in cancer vs normal | 22628229 |
CancerPDF_ID3340 | NA | NA | Serum | 2093.19 | MALDI-TOF | Non-small cell lung cancer (NSCLC) | Downregulated in cancer vs normal | 22628229 |
CancerPDF_ID3341 | NA | NA | Serum | 7563.83 | MALDI-TOF | Non-small cell lung cancer (NSCLC) | Downregulated in cancer vs normal | 22628229 |
CancerPDF_ID3342 | NA | NA | Serum | 6047.64 | MALDI-TOF | Non-small cell lung cancer (NSCLC) | Upregulated in cancer vs normal | 22628229 |
CancerPDF_ID3343 | NA | NA | Serum | 7920.5 | MALDI-TOF | Non-small cell lung cancer (NSCLC) | Downregulated in cancer vs normal | 22628229 |
CancerPDF_ID3344 | NA | NA | Serum | 8139.21 | MALDI-TOF | Non-small cell lung cancer (NSCLC) | Downregulated in cancer vs normal | 22628229 |
CancerPDF_ID3345 | NA | NA | Serum | 2932.99 | MALDI-TOF | Non-small cell lung cancer (NSCLC) | Upregulated in cancer vs normal | 22628229 |
CancerPDF_ID3346 | NA | NA | Serum | 1887.15 | MALDI-TOF | Non-small cell lung cancer (NSCLC) | Upregulated in cancer vs normal | 22628229 |
CancerPDF_ID3347 | NA | NA | Serum | 1897.93 | MALDI-TOF | Non-small cell lung cancer (NSCLC) | Upregulated in cancer vs normal | 22628229 |
CancerPDF_ID3348 | NA | NA | Serum | 3883.45 | MALDI-TOF | Non-small cell lung cancer (NSCLC) | Downregulated in cancer vs normal | 22628229 |
CancerPDF_ID3349 | NA | NA | Serum | 1741.38 | MALDI-TOF | Non-small cell lung cancer (NSCLC) | Upregulated in cancer vs normal | 22628229 |
CancerPDF_ID3350 | NA | NA | Serum | 3952.19 | MALDI-TOF | Non-small cell lung cancer (NSCLC) | Downregulated in cancer vs normal | 22628229 |
CancerPDF_ID3351 | NA | NA | Serum | 7468.37 | MALDI-TOF | Non-small cell lung cancer (NSCLC) | Upregulated in cancer vs normal | 22628229 |
CancerPDF_ID3352 | NA | NA | Serum | 5292.77 | MALDI-TOF | Non-small cell lung cancer (NSCLC) | Upregulated in cancer vs normal | 22628229 |
CancerPDF_ID3353 | NA | NA | Serum | 5079.68 | MALDI-TOF | Non-small cell lung cancer (NSCLC) | Upregulated in cancer vs normal | 22628229 |
CancerPDF_ID3354 | NA | NA | Serum | 1350.83 | MALDI-TOF | Non-small cell lung cancer (NSCLC) | Upregulated in cancer vs normal | 22628229 |
CancerPDF_ID3355 | NA | NA | Serum | 2554.64 | MALDI-TOF | Non-small cell lung cancer (NSCLC) | Upregulated in cancer vs normal | 22628229 |
CancerPDF_ID3356 | NA | NA | Serum | 4529.7 | MALDI-TOF | Non-small cell lung cancer (NSCLC) | Upregulated in cancer vs normal | 22628229 |
CancerPDF_ID3357 | NA | NA | Serum | 1012.61 | MALDI-TOF | Non-small cell lung cancer (NSCLC) | Downregulated in cancer vs normal | 22628229 |
CancerPDF_ID3358 | NA | NA | Serum | 1519.98 | MALDI-TOF | Non-small cell lung cancer (NSCLC) | Downregulated in cancer vs normal | 22628229 |
CancerPDF_ID3359 | NA | NA | Serum | 1945.53 | MALDI-TOF | Non-small cell lung cancer (NSCLC) | Downregulated in cancer vs normal | 22628229 |
CancerPDF_ID3360 | NA | NA | Serum | 2669.09 | MALDI-TOF | Non-small cell lung cancer (NSCLC) | Upregulated in cancer vs normal | 22628229 |
CancerPDF_ID3361 | NA | NA | Serum | 2878.89 | MALDI-TOF | Non-small cell lung cancer (NSCLC) | Upregulated in cancer vs normal | 22628229 |
CancerPDF_ID3362 | NA | NA | Serum | 3208.49 | MALDI-TOF | Non-small cell lung cancer (NSCLC) | Upregulated in cancer vs normal | 22628229 |
CancerPDF_ID3363 | NA | NA | Serum | 3934.92 | MALDI-TOF | Non-small cell lung cancer (NSCLC) | Downregulated in cancer vs normal | 22628229 |
CancerPDF_ID3364 | NA | NA | Serum | 4153.16 | MALDI-TOF | Non-small cell lung cancer (NSCLC) | Downregulated in cancer vs normal | 22628229 |
CancerPDF_ID3365 | NA | NA | Serum | 5264.02 | MALDI-TOF | Non-small cell lung cancer (NSCLC) | Upregulated in cancer vs normal | 22628229 |
CancerPDF_ID3366 | NA | NA | Serum | 6387.9 | MALDI-TOF | Non-small cell lung cancer (NSCLC) | Downregulated in cancer vs normal | 22628229 |
CancerPDF_ID3367 | NA | NA | Serum | 6529.26 | MALDI-TOF | Non-small cell lung cancer (NSCLC) | Downregulated in cancer vs normal | 22628229 |
CancerPDF_ID3368 | NA | NA | Serum | 6937.21 | MALDI-TOF | Non-small cell lung cancer (NSCLC) | Downregulated in cancer vs normal | 22628229 |
CancerPDF_ID3369 | NA | NA | Serum | 2953.31 | MALDI-TOF | Non-small cell lung cancer (NSCLC) | Upregulated in cancer vs normal | 22628229 |
CancerPDF_ID3370 | NA | NA | Serum | 1450.55 | MALDI-TOF | Non-small cell lung cancer (NSCLC) | Upregulated in cancer vs normal | 22628229 |
CancerPDF_ID3371 | NA | NA | Serum | 1779.31 | MALDI-TOF | Non-small cell lung cancer (NSCLC) | Upregulated in cancer vs normal | 22628229 |
CancerPDF_ID3372 | NA | NA | Serum | 7007.25 | MALDI-TOF | Non-small cell lung cancer (NSCLC) | Downregulated in cancer vs normal | 22628229 |
CancerPDF_ID3373 | NA | NA | Serum | 4194.12 | MALDI-TOF | Non-small cell lung cancer (NSCLC) | Downregulated in cancer vs normal | 22628229 |
CancerPDF_ID3374 | NA | NA | Serum | 7651.87 | MALDI-TOF | Non-small cell lung cancer (NSCLC) | Downregulated in cancer vs normal | 22628229 |
CancerPDF_ID3375 | NA | NA | Serum | 8562.86 | MALDI-TOF | Non-small cell lung cancer (NSCLC) | Upregulated in cancer vs normal | 22628229 |
CancerPDF_ID3376 | NA | NA | Serum | 1082.44 | MALDI-TOF | Non-small cell lung cancer (NSCLC) | Upregulated in cancer vs normal | 22628229 |
CancerPDF_ID3377 | NA | NA | Serum | 2769.86 | MALDI-TOF | Non-small cell lung cancer (NSCLC) | Upregulated in cancer vs normal | 22628229 |
CancerPDF_ID3378 | NA | NA | Serum | 5753.12 | MALDI-TOF | Non-small cell lung cancer (NSCLC) | Upregulated in cancer vs normal | 22628229 |
CancerPDF_ID3379 | NA | NA | Serum | 4281.54 | MALDI-TOF | Non-small cell lung cancer (NSCLC) | Upregulated in cancer vs normal | 22628229 |
CancerPDF_ID3380 | NA | NA | Serum | 1207.13 | MALDI-TOF | Non-small cell lung cancer (NSCLC) | Downregulated in cancer vs normal | 22628229 |
CancerPDF_ID3381 | NA | NA | Serum | 4169.93 | MALDI-TOF | Non-small cell lung cancer (NSCLC) | Downregulated in cancer vs normal | 22628229 |
CancerPDF_ID3382 | NA | NA | Serum | 8762.73 | MALDI-TOF | Non-small cell lung cancer (NSCLC) | Downregulated in cancer vs normal | 22628229 |
CancerPDF_ID3383 | NA | NA | Serum | 1563.43 | MALDI-TOF | Non-small cell lung cancer (NSCLC) | Upregulated in cancer vs normal | 22628229 |
CancerPDF_ID3384 | NA | NA | Serum | 1331.12 | MALDI-TOF | Non-small cell lung cancer (NSCLC) | Upregulated in cancer vs normal | 22628229 |
CancerPDF_ID3385 | NA | NA | Serum | 2545.83 | MALDI-TOF | Non-small cell lung cancer (NSCLC) | Upregulated in cancer vs normal | 22628229 |
CancerPDF_ID3386 | NA | NA | Serum | 1866.42 | MALDI-TOF | Non-small cell lung cancer (NSCLC) | Upregulated in cancer vs normal | 22628229 |
CancerPDF_ID3387 | NA | NA | Serum | 8812.29 | MALDI-TOF | Non-small cell lung cancer (NSCLC) | Downregulated in cancer vs normal | 22628229 |
CancerPDF_ID3388 | NA | NA | Serum | 1945.53 | MALDI-TOF | Non-small cell lung cancer (NSCLC) | Downregulated in cancer vs normal | 22628229 |
CancerPDF_ID3389 | NA | NA | Serum | 2281.08 | MALDI-TOF | Non-small cell lung cancer (NSCLC) | Upregulated in cancer vs normal | 22628229 |
CancerPDF_ID3390 | NA | NA | Serum | 1563.11 | MALDI-TOF | Non-small cell lung cancer (NSCLC) | Upregulated in cancer vs normal | 22628229 |
CancerPDF_ID3391 | NA | NA | Serum | 2281.08 | MALDI-TOF | Non-small cell lung cancer (NSCLC) | Upregulated in cancer vs normal | 22628229 |
CancerPDF_ID3392 | NA | NA | Serum | 2682.65 | MALDI-TOF | Non-small cell lung cancer (NSCLC) | Upregulated in cancer vs normal | 22628229 |
CancerPDF_ID3393 | NA | NA | Serum | 2900.91 | MALDI-TOF | Non-small cell lung cancer (NSCLC) | Upregulated in cancer vs normal | 22628229 |
CancerPDF_ID3394 | NA | NA | Serum | 3279.09 | MALDI-TOF | Non-small cell lung cancer (NSCLC) | Upregulated in cancer vs normal | 22628229 |
CancerPDF_ID3395 | NA | NA | Serum | 4054.17 | MALDI-TOF | Non-small cell lung cancer (NSCLC) | Downregulated in cancer vs normal | 22628229 |
CancerPDF_ID3396 | NA | NA | Serum | 5247.81 | MALDI-TOF | Non-small cell lung cancer (NSCLC) | Upregulated in cancer vs normal | 22628229 |
CancerPDF_ID3397 | NA | NA | Serum | 5336.3 | MALDI-TOF | Non-small cell lung cancer (NSCLC) | Upregulated in cancer vs normal | 22628229 |
CancerPDF_ID3398 | NA | NA | Serum | 6431.4 | MALDI-TOF | Non-small cell lung cancer (NSCLC) | Downregulated in cancer vs normal | 22628229 |
CancerPDF_ID3399 | NA | NA | Serum | 6629.53 | MALDI-TOF | Non-small cell lung cancer (NSCLC) | Downregulated in cancer vs normal | 22628229 |
CancerPDF_ID3400 | NA | NA | Serum | 8686.87 | MALDI-TOF | Non-small cell lung cancer (NSCLC) | Downregulated in cancer vs normal | 22628229 |